Literature DB >> 19405102

The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1.

Hideaki Kume1, Kiyoko S Murayama, Wataru Araki.   

Abstract

beta-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is a membrane-bound protease that is essential for the production of beta-amyloid protein (Abeta). Given the crucial role of Abeta accumulation in Alzheimer's disease (AD), inhibition of BACE1 activity may represent a feasible therapeutic strategy in the treatment of AD. Recently, we and others identified reticulon 3 (RTN3) and reticulon 4-B/C (RTN4-B/C or Nogo-B/C) as membrane proteins that interact with BACE1 and inhibit its ability to produce Abeta. In this study, we employed various mutants of RTN3 and RTN4-C and C. elegans RTN to investigate the molecular mechanisms by which RTNs regulate BACE1. We found that RTN3 mutants lacking the N-terminal or C-terminal or loop domain as well as a RTN4-C mutant lacking the C-terminal domain bound to BACE1 comparably to wild-type RTN3 and RTN4-C. Furthermore, overexpression of wild-type RTN3, RTN4-C, and these RTN mutants similarly reduced Abeta40 and Abeta42 secretion by cells expressing Swedish mutant APP. C. elegans RTN, which has low homology to human RTNs, also interacted with BACE1 and inhibited Abeta secretion. In contrast, two RTN3 mutants containing deletions of the first or second potential transmembrane domains and an RTN3 swap mutant of the second transmembrane domain bound BACE1 but failed to inhibit Abeta secretion. Collectively, these results suggest that the two-transmembrane-domain tertiary structure of RTN proteins is critical for the ability of RTNs to modulate BACE1 activity, whereas N-terminal, C-terminal and loop regions are not essential for this function. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405102     DOI: 10.1002/jnr.22112

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  9 in total

1.  RTN/Nogo in forming Alzheimer's neuritic plaques.

Authors:  Marguerite Prior; Qi Shi; Xiangyou Hu; Wanxia He; Allan Levey; Riqiang Yan
Journal:  Neurosci Biobehav Rev       Date:  2010-02-06       Impact factor: 8.989

2.  Increased expression of reticulon 3 in neurons leads to reduced axonal transport of β site amyloid precursor protein-cleaving enzyme 1.

Authors:  Minzi Deng; Wanxia He; Ya Tan; Hailong Han; Xiangyou Hu; Kun Xia; Zhuohua Zhang; Riqiang Yan
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

3.  Identification of rare RTN3 variants in Alzheimer's disease in Han Chinese.

Authors:  Yongyi Zou; Wanxia He; Kangli Wang; Hailong Han; Tingting Xiao; Xumeng Chen; Bin Zhou; Jieqiong Tan; Kun Xia; Beisha Tang; Chao Chen; Lu Shen; Riqiang Yan; Zhuohua Zhang
Journal:  Hum Genet       Date:  2018-01-22       Impact factor: 4.132

4.  Finding New Ways How to Control BACE1.

Authors:  Jarmila Nahálková
Journal:  J Membr Biol       Date:  2022-03-19       Impact factor: 1.843

Review 5.  ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum.

Authors:  Fulvio Reggiori; Maurizio Molinari
Journal:  Physiol Rev       Date:  2022-02-21       Impact factor: 46.500

6.  Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.

Authors:  Qi Shi; Marguerite Prior; Wanxia He; Xiangying Tang; Xiangyou Hu; Riqiang Yan
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

Review 7.  The role of reticulons in neurodegenerative diseases.

Authors:  Valerio Chiurchiù; Mauro Maccarrone; Antonio Orlacchio
Journal:  Neuromolecular Med       Date:  2013-11-12       Impact factor: 3.843

Review 8.  The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches.

Authors:  Agnieszka Kulczyńska-Przybik; Piotr Mroczko; Maciej Dulewicz; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

9.  Exploring novel mechanistic insights in Alzheimer's disease by assessing reliability of protein interactions.

Authors:  Ashutosh Malhotra; Erfan Younesi; Sudeep Sahadevan; Joerg Zimmermann; Martin Hofmann-Apitius
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.